On Thursday, Ed Morrissey at Hot Air posted an article about Health and Human Services using the rule-making process to prevent the federal government from directly funding sex-altering procedures on minors. Medicaid and the Children’s Health Insurance Program (CHIP), National Review currently fund these procedures.
The article quotes The National Review:
The Department of Health and Human Services will soon begin the rule-making process to prohibit the federal government from directly funding sex-trait modifications for minors through Medicaid and the Children’s Health Insurance Program (CHIP), National Review has learned.
The White House is in “the final stage of review for a new rule that would make it a condition of hospitals participating in Medicare or Medicaid that they not provide sex trait modifications to minors,” according to an administration official. The prohibition will apply to hospitals that provide puberty blockers, cross-sex hormones, and gender-transition surgeries to minors.
The groundbreaking decision by the White House to use the power of the executive to ban federally funded gender-transition services for minors follows an unsuccessful attempt by congressional Republicans to ban federal funding for such practices through the budget reconciliation process. The Senate parliamentarian ruled that the legislative language included in the “One Big Beautiful Bill Act” did not clear the Byrd rule, prompting GOP lawmakers to spike the language from the final bill that passed earlier this month.
The article explains the significance of using the rules process for this item:
How do we know this will happen? Using the rules process practically ensures it. Most administrations make the mistake of skipping over these steps in haste to make their point, but courts take the Administrative Procedure Act very seriously. An executive order does not overcome the APA in matters such as these. The use of the rulemaking process will slow this down, but it will also ensure that the changes will be legally bulletproof, or as bulletproof as activist district courts allow them to be.
The article concludes:
…If providers are defrauding Medicare and Medicaid to get paid directly for pediatric sex-change therapies, their CMS funding can stop immediately. HHS has the authority to enforce its rules by suspending or excluding providers engaged in fraud from federal repayments, and the DoJ can and often does take up those cases on a criminal basis as well.
The best part of this will be the rethinking it will require. The UK has already cut its support for pediatric sex-change therapies after the Cass Review determined that puberty blockers did nothing to address pediatric gender dysphoria while essentially sterilizing children. Another major study on the issue here in the US got suppressed last year for allegedly coming to the same conclusion. Both HHS and the DoJ are already investigating several cases of detransitioners who claim now to have gotten pressured into life-changing surgeries and therapies by providers who also receive CMS funding.
HHS sent a warning signal in May over the lack of sound scientific or medical evidence for pediatric sex-change therapies. This is just the next shoe dropping on radicalized providers pushing fad medicine and maiming children for virtue signaling. It won’t be the last.
This is child abuse and needs to be stopped. Cutting off the federal funding is a good first step in that direction.